VERTEX PHARMACEUTICALS INC / MA Quarterly Lessee, Operating Lease, Liability, to be Paid in USD from Q1 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Vertex Pharmaceuticals Inc / Ma quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q1 2019 to Q4 2023.
  • Vertex Pharmaceuticals Inc / Ma Lessee, Operating Lease, Liability, to be Paid for the quarter ending December 31, 2023 was $436M, a 11.2% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $436M -$55.2M -11.2% Dec 31, 2023 10-K 2024-02-15
Q4 2022 $491M +$9.1M +1.89% Dec 31, 2022 10-K 2023-02-10
Q4 2021 $482M +$11.8M +2.51% Dec 31, 2021 10-K 2022-02-09
Q4 2020 $470M +$355M +308% Dec 31, 2020 10-K 2021-02-11
Q4 2019 $115M Dec 31, 2019 10-K 2020-02-13
Q3 2019 $88M Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $85.4M Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $89M Mar 31, 2019 10-Q 2019-05-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.